Search - tctmd.com

Displaying 161 - 180 of 382

Sort: Relevancy | Date

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for August 2020

Caitlin E. Cox

August 28, 2020

News Daily News

CV Prevention Meds Underused in Hispanic, Latinx PAD Patients

L.A. McKeown

August 12, 2020

News Daily News

Higher BP May Limit Myocardial Injury in AMICS

Caitlin E. Cox

August 10, 2020

News Daily News

Rosuvastatin-Canagliflozin Combo May Be Toxic, Case Suggests

Todd Neale

August 03, 2020

News Daily News

Heart, Kidneys, Brain, and More: COVID-19’s Wide-ranging Effects

Michael O'Riordan

July 13, 2020

News Daily News

One in Three Hospitalizations After Acute MI Go Unreported

L.A. McKeown

July 03, 2020

News Daily News

Possible Antithrombotic and Anti-inflammatory Therapies for COVID-19

Michael O'Riordan

June 08, 2020

News Daily News

Risk of Dying Doubled in Wuhan COVID-19 Patients With Hypertension

L.A. McKeown

June 08, 2020

News Daily News

Injectable P2Y12 Inhibitor Selatogrel Shows Promise in Acute MI

Yael L. Maxwell

June 03, 2020

News Daily News

P2Y12 Inhibitor Monotherapy Edges Out Aspirin for Secondary Prevention

Yael L. Maxwell

May 15, 2020

News Daily News

FOURIER Surveys Reassure About Cognitive Safety of Evolocumab

Todd Neale

May 06, 2020

News Features

Hopes High for Anti-inflammatories to Combat COVID-19 Immune System Storms

Caitlin E. Cox

April 23, 2020

News Features

The Mystery of the Missing STEMIs During the COVID-19 Pandemic

Shelley Wood

April 02, 2020

News Conference News ACC 2020

Pooled Inclisiran Data: Safe LDL-Lowering, Plus Hints of Fewer CVD Events

Michael O'Riordan

April 02, 2020

News Conference News ACC 2020

PCI Equal to Surgery in Left Main CAD: PRECOMBAT at 10 Years

Michael O'Riordan

March 30, 2020

News Conference News ACC 2020

Safety, Efficacy of Ticagrelor Monotherapy Confirmed in Complex PCI, Diabetes

Yael L. Maxwell

March 30, 2020

News Conference News ACC 2020

Genotype-Based P2Y12 Prescribing Post-PCI Falls Short in TAILOR-PCI

Yael L. Maxwell

March 28, 2020

News Daily News

Validated ARC-HBR Criteria Highlight ‘Eye-opening’ Proportion of PCI Patients at Risk

Yael L. Maxwell

March 03, 2020

News Daily News

Stent-Related Adverse Events Continue Out to 5 Years: Meta-analysis

Michael O'Riordan

February 10, 2020

News Features

The Cancer Patient Needing PCI Poses Conundrums for Care

Shelley Wood

January 14, 2020

Advertisement

TCTMD’s Top 10 Most Popular Stories for August 2020

CV Prevention Meds Underused in Hispanic, Latinx PAD Patients

Higher BP May Limit Myocardial Injury in AMICS

Rosuvastatin-Canagliflozin Combo May Be Toxic, Case Suggests

Heart, Kidneys, Brain, and More: COVID-19’s Wide-ranging Effects

One in Three Hospitalizations After Acute MI Go Unreported

Possible Antithrombotic and Anti-inflammatory Therapies for COVID-19

Risk of Dying Doubled in Wuhan COVID-19 Patients With Hypertension

Injectable P2Y12 Inhibitor Selatogrel Shows Promise in Acute MI

P2Y12 Inhibitor Monotherapy Edges Out Aspirin for Secondary Prevention

FOURIER Surveys Reassure About Cognitive Safety of Evolocumab

Hopes High for Anti-inflammatories to Combat COVID-19 Immune System Storms

The Mystery of the Missing STEMIs During the COVID-19 Pandemic

Pooled Inclisiran Data: Safe LDL-Lowering, Plus Hints of Fewer CVD Events

PCI Equal to Surgery in Left Main CAD: PRECOMBAT at 10 Years

Safety, Efficacy of Ticagrelor Monotherapy Confirmed in Complex PCI, Diabetes

Genotype-Based P2Y12 Prescribing Post-PCI Falls Short in TAILOR-PCI

Validated ARC-HBR Criteria Highlight ‘Eye-opening’ Proportion of PCI Patients at Risk

Stent-Related Adverse Events Continue Out to 5 Years: Meta-analysis

The Cancer Patient Needing PCI Poses Conundrums for Care

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content